Connect with us

Hi, what are you looking for?


Options Prospectus

Cardiex Limited (ASX:CDX) (Cardiex, the Company) is pleased to share its Options Prospectus.

This Prospectus is being issued for an offer of up to 27,000,000 Quoted Options exercisable at $0.20 each and expiring at 5:00pm (AEST) on 30 November 2025 (Quoted Options) comprising of the following offers:

1. an offer of up to 25,000,000 Quoted Options to C2 Ventures Pty Limited; and

2. up to 2,000,000 Quoted Options to Directors, Mr Charles Taylor and Mr Randall King Nelson (or their nominees); (together, the Offer).

The Offer under this Prospectus closes at 5.00pm (AEST) on 25 June 2024.*

Click here for the full ASX Release

This post appeared first on

You May Also Like

Editor's Pick

After the final lecture of my Fall 2022 International Economic Policy course (an undergraduate offering meant to introduce non-economics majors to the economics of...

Editor's Pick

Real gross domestic product rose at a revised 3.2 percent annualized rate in the third quarter versus a 0.6 percent rate of decline in...

Editor's Pick

For years the North Korean playbook was obvious to the world. The Democratic People’s Republic of Korea wanted to be the center of attention....

Editor's Pick

On April 23, 1985, the Coca-Cola Company made one of the biggest mistakes in American business history: it changed the formula for Coca-Cola. Outraged...

Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024